A BMJ journal has published an updated analysis of a 2007 paper that shaped current car seat safety recommendations, which reports less conclusive findings about the safest way to install the seat.
The updated analysis follows an expression of concern the journal Injury Prevention added to the paper in June 2017, after the authors and an outside expert could not replicate the results.
The 2007 paper made a big claim: Children ages one to two years old are five times more likely to sustain serious injuries in a crash when restrained in a forward-facing car seat than a rear-facing seat.
What Caught Our Attention: Informative retraction notices can be infrequent, but rarer still are notices that fulfill an oft-ignored function: To be a source of learning for others in the field. Here, the authors offer a nearly 800-word “detailed description of the issues” with “some observations that may be useful for investigators conducting similar studies.” These authors embraced the retraction process, carefully explaining their findings or the lack thereof, for each figure from their now-retracted paper. Continue reading Caught Our Notice: A retraction that is “useful for investigators”
A former professor at the University of Washington, Brodie is currently involved in his third lawsuit challenging afinding of scientific misconduct and a seven-year funding ban handed down in 2010 by the U.S. Department of Health and Human Services’ Office of Research Integrity. He says that in the time since his case was heard by an administrative law judge at the ORI level, new evidence has come to light that shows he “did not have a ‘full and fair opportunity to litigate’ the issues.” His lawsuit sought a court order to have the ORI revisit its decision.
Last year, a U.S. District Court judge dismissed the case, saying it revisited old issues that had already been litigated, but Brodie appealed that decision. Now, his quest may have come to an end: On Nov. 27, the U.S. Court of Appeals for the D.C. Circuit dismissed the appeal. If he wants to continue the case, Brodie’s only remaining option is to appeal the decision to the U.S. Supreme Court.
In the court order, the panel of three judges wrote:
Last year, a professor brought a suit against his former university after it forced him to retire. Now, he’s adding defamation to his list of allegations.
In a lawsuit filed July 14, 2016, Ishwarlal “Kenny” Jialal, a cardiovascular researcher who worked at the University of California, Davis Medical Center from 2002 to 2016, alleges the school breached the separation agreement that led to his ouster. The university forced him to retire following a misconduct inquiry in which he was cleared of wrongdoing, and later stripped him of emeritus status. Before a trial date could be set, Jialal decided he wanted to add to the list of allegations; in an amended complaint filed Oct. 23, 2017, he says individuals at UC Davis badmouthed him to a potential employer and cost him a job.
Jialal is seeking unspecified monetary damages, an order that would rescind the separation agreement that led to his departure, injunctive relief, and attorney’s’ fees and other costs related to the suit.
A Nobel Laureate has retracted a 2016 paper in Nature Chemistry that explored the origins of life on earth, after discovering the main conclusions were not correct.
Some researchers who study the origins of life on Earth have hypothesized that RNA evolved before DNA or proteins. If true, RNA would have needed a way to replicate without enzymes. The Nature Chemistry paper found that a certain type of peptide — which may have existed in our early history — made it possible for RNA to copy itself.
Jack W. Szostak—a professor of chemistry and chemical biology at Harvard University in Cambridge, Mass., who shared the 2009 Nobel Prize in Physiology or Medicine with Elizabeth Blackburn and Carol Greider for their pioneering research on aging—told us he was “incredibly excited” when he “thought we had at least a partial solution to this problem,” which researchers have been working on for over 50 years.
But in subsequent experiments, Tivoli Olsen — a member of Szostak’s lab — could not reproduce the 2016 findings. When she reviewed the experiments from the Nature Chemistry paper, she found that the team had misinterpreted the initial data: The peptide in question did not appear to provide an environment that fostered RNA replication.
The U.S. National Institutes of Health has noticed something: More of the research it’s funding is ending up in questionable journals. Recently, the agency issued a statement highlighting some qualities of these journals — aggressively soliciting submissions, failing to provide clear information about pricing — and urging researchers to avoid them. The NIH’s goal: to “help protect the credibility of papers arising from its research investment.” We asked the NIH for more information about the guide notice; a representative returned responses, asking that we attribute them to the NIH Office of Extramural Research.
Retraction Watch: What prompted the NIH to issue this guide notice? Was there an incident?
Alexander Neumeister. Source: Yale School of Medicine
A researcher specializing in post-traumatic stress disorder is facing jail time for allegedly embezzling tens of thousands of dollars of federal grant money.
Yesterday, the US Attorney’s Office for the Southern District of New York and the U.S. Department of Health and Human Services’s Office of Inspector General (OIG) announced criminal charges against Alexander Neumeister, alleging he used the grant funds on trips and meals for family and friends. As the New York Times reported last year, Neumeister was dismissed from his position at New York University (NYU); NYU shut down eight of his studies following an investigation by the U.S. Food and Drug Administration, which found evidence of lax oversight, falsified records, and inaccurate case histories.
The U.S. Attorney has also filed a civil lawsuit against Neumeister under the False Claims Act, also for misuse of grant funding. The complaint does not specify the total amount of funds he allegedly misused.
In a statement, Acting U.S. Attorney Joon Kim said Neumeister:
Researchers have retracted a 2017 paper exploring a novel approach to treat kidney injury, because three images were “constructed inappropriately.”
That’s about as much as we know: The retraction notice provides few details about the nature of the issue, only that the authors—most of whom work at Pennsylvania State University College of Medicine in Hershey—could not provide the original data for the recently published figures.